Home Newsfeeds Raymond James Downgrades Focus Finl Partners to Market Perform

Raymond James Downgrades Focus Finl Partners to Market Perform

Raymond James analyst Patrick O'Shaughnessy downgrades Focus Finl Partners (NASDAQ:FOCS) from Outperform to Market Perform.

byBenzinga Newsdesk

February 17, 2023

1 minute read

Raymond James analyst Patrick O’Shaughnessy downgrades Focus Finl Partners (NASDAQ:FOCS) from Outperform to Market Perform.

HP Gets Price Target Bumps By Analysts After Q2 Results

By Lisa Levin

May 31, 7:35 AM

HP Inc. (NYSE: HPQ) reported better-than-expected earnings for its second quarter, while sales missed expectations.

HPQ

Monte Rosa Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Size Or Amount Disclosed

By Benzinga Newsdesk

May 15, 4:13 PM

Monte Rosa Therapeutics, Inc. ("Monte Rosa") (NASDAQ:GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that it has commenced an underwritten

GLUE

Curaleaf Is One Step Closer To Trading On Toronto Stock Exchange

By Jelena Martinovic

December 8, 9:29 AM

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has received conditional approval from the Toronto Stock Exchange to list its subordinate voting shares on the TSX.

CSE:CURA

Elon Musk Tweeted: 2023 Will Probably Be Tough, but My Companies Are Positioned Well

By Charles Gross

November 11, 6:03 AM

https://twitter.com/elonmusk/status/1590982855387418627?s=20&t=yACJxzAHvuru1ZD_0-jMXg

TSLA

Raymond James Downgrades Focus Finl Partners to Market Perform

Related Posts

HP Gets Price Target Bumps By Analysts After Q2 Results

Monte Rosa Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Size Or Amount Disclosed

Curaleaf Is One Step Closer To Trading On Toronto Stock Exchange

Elon Musk Tweeted: 2023 Will Probably Be Tough, but My Companies Are Positioned Well